Diabetes diagnostics developer Zenomics has received $5.8m from biomedical device producer MicroPort Scientific in the first tranche of its first funding round.
Zenomics, a US-based diabetes analysis-focused medical spinout from University of North Carolina (UNC) at Chapel Hill, today raised $5.8m from biomedical device manufacturer MicroPort Scientific.
Zhen Gu, a biomedical engineer with joint faculty appointments at UNC and North Carolina (NC) State University, founded Zenomics in 2015 to develop a microneedle transdermal patch the size of a coin to help manage diabetes.
Hundreds of microneedles on the patch administer insulin via minuscule tanks which also contain glucose sensors, allowing patients to…
